Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132461) titled 'Prospective observation of FABP4 and its related signaling axis expression in the placental immune microenvironment of patients with gestational diabetes and its impact on macrophage polarization' on Sept. 14.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of fujian medical university
Condition:
gestational diabetes mellitus
Intervention:
GDM group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: GDM group:20;Normal Control Group:20;
Countries of Recruitment:
China
To know ...